HGH Fragment 176-191 10mg Research Peptide
HGH Fragment 176-191 is a synthetic peptide corresponding to amino acids 176–191 of the C-terminal region of human growth hormone, retaining selective lipolytic activity without the mitogenic, IGF-1-mediated, or insulin-desensitizing effects of full-length GH. This 10mg vial provides a larger research quantity of HGH Fragment 176-191 at ≥99% purity, suitable for extended protocols or multi-model studies. HPLC and MS/MS verified per batch with third-party COA available.
Research Background
Preclinical research from Monash University established that HGH Fragment 176-191 stimulates lipolysis and inhibits lipogenesis in adipocyte models at concentrations where full GH would also produce IGF-1-mediated growth effects. This selectivity makes it a valuable tool for studying isolated fat metabolism pathways. Rodent studies showed dose-dependent reductions in body fat mass — particularly visceral fat — without changes in lean mass, glucose tolerance, or linear growth, enabling cleaner metabolic research designs than full GH protocols.
Compound Specifications
- Format: Lyophilized powder
- Purity: ≥99% (HPLC verified)
- Quantity: 10mg per vial
- Storage: −20°C, protected from light
- Sequence: Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Weight: 1817.1 Da
Certificate of Analysis
Third-party tested by independent ISO-certified laboratories. HPLC and MS/MS validation performed per batch. COA available on request.
For research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.
